BIOMERICA INC Cash and Restricted Cash
BIOMERICA INC (BMRA) had Cash and Restricted Cash of $3.35 million as of 2023-02-28, per its 10-Q filed 2023-04-14.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-04-14
- 2023-02-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.35M.
- 2022-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.07M.
- 2022-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.08M.
- 2022-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.92M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2023-02-28 | $3.35M 10-Q · filed 2023-04-14 |
| 2022-11-30 | $5.07M 10-Q · filed 2023-01-13 |
| 2022-08-31 | $6.08M 10-Q · filed 2022-10-13 |
| 2022-05-31 | $5.92M 10-Q · filed 2023-04-14 |
| 2022-02-28 | $10.17M 10-Q · filed 2023-04-14 |
| 2021-11-30 | $7.20M 10-Q · filed 2023-01-13 |
| 2021-08-31 | $5.00M 10-Q · filed 2022-10-13 |
| 2021-05-31 | $4.20M 10-Q · filed 2023-04-14 |
| 2021-02-28 | $5.27M 10-Q · filed 2022-04-14 |
| 2020-05-31 | $8.64M 10-K · filed 2022-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |